These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7854351)
21. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid. Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903 [TBL] [Abstract][Full Text] [Related]
22. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation. Su ZZ; Yemul S; Stein CA; Fisher PB Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104 [TBL] [Abstract][Full Text] [Related]
23. Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Bellingham DL; Sar M; Cidlowski JA Mol Endocrinol; 1992 Dec; 6(12):2090-102. PubMed ID: 1491690 [TBL] [Abstract][Full Text] [Related]
24. Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Clohisy JC; Scott DK; Brakenhoff KD; Quinn CO; Partridge NC Mol Endocrinol; 1992 Nov; 6(11):1834-42. PubMed ID: 1480173 [TBL] [Abstract][Full Text] [Related]
25. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 regulation of corticotropin-releasing factor (CRF), glucocorticoid receptor, c-fos and c-jun messenger RNA in the NPLC-KC cell line. Gill PS; Regmi A; Porter-Gill PA; Kasckow JW Mol Cell Endocrinol; 1998 Feb; 137(1):31-9. PubMed ID: 9607726 [TBL] [Abstract][Full Text] [Related]
28. Retinoic acid inhibition of serum-induced c-fos transcription in a fibrosarcoma cell line. Jaffey P; Chan LN; Shao J; Schneider-Schaulies J; Chan TS Cancer Res; 1992 May; 52(9):2384-8. PubMed ID: 1568207 [TBL] [Abstract][Full Text] [Related]
29. Differential regulation by c-jun and c-fos protooncogenes of hormone response from composite glucocorticoid response element in human papilloma virus type 16 regulatory region. Mittal R; Kumar KU; Pater A; Pater MM Mol Endocrinol; 1994 Dec; 8(12):1701-8. PubMed ID: 7708058 [TBL] [Abstract][Full Text] [Related]
30. Differential autoregulation of glucocorticoid receptor expression in human T- and B-cell lines. Denton RR; Eisen LP; Elsasser MS; Harmon JM Endocrinology; 1993 Jul; 133(1):248-56. PubMed ID: 8319574 [TBL] [Abstract][Full Text] [Related]
31. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403 [TBL] [Abstract][Full Text] [Related]
32. Thyrotropin-releasing hormone stimulates in parallel jun B and c-fos messenger ribonucleic acids in GH3B6 pituitary cells: comparison with PRL secretion. Passegue E; Laverriere JN; Gourdji D Mol Cell Neurosci; 1994 Apr; 5(2):109-18. PubMed ID: 8032680 [TBL] [Abstract][Full Text] [Related]
33. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834 [TBL] [Abstract][Full Text] [Related]
34. The protein kinase A pathway inhibits c-jun and c-fos protooncogene expression induced by the protein kinase C and tyrosine kinase pathways in cultured human thyroid follicles. Heinrich R; Kraiem Z J Clin Endocrinol Metab; 1997 Jun; 82(6):1839-44. PubMed ID: 9177393 [TBL] [Abstract][Full Text] [Related]
35. Estradiol stimulation of c-fos and c-jun expressions and activator protein-1 deoxyribonucleic acid binding activity in rat white adipocyte. Garcia E; Lacasa D; Giudicelli Y Endocrinology; 2000 Aug; 141(8):2837-46. PubMed ID: 10919270 [TBL] [Abstract][Full Text] [Related]
36. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis. Morello D; Lavenu A; Babinet C Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531 [TBL] [Abstract][Full Text] [Related]
38. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells. Davidson NE; Prestigiacomo LJ; Hahm HA Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822 [TBL] [Abstract][Full Text] [Related]
39. Phorbol ester inhibition of rat gonadotropin-releasing hormone promoter activity: role of Fos and Jun in the repression of transcription. Bruder JM; Spaulding AJ; Wierman ME Mol Endocrinol; 1996 Jan; 10(1):35-44. PubMed ID: 8838143 [TBL] [Abstract][Full Text] [Related]
40. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells. Fang MA; Kujubu DA; Hahn TJ Endocrinology; 1992 Nov; 131(5):2113-9. PubMed ID: 1330491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]